Head-to-head dispatch
Alloy vs RxSpan MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Alloy is a menopause-focused telehealth brand whose Weight Care program runs the broadest GLP-1 formulary in our catalog — brand Wegovy, brand Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide…
Marked down on: Menopause-focused — best for women in menopause or perimenopause, not men or younger patients
Desk Score
A physician-founded desk with one of the widest menus in the ranking — compounded and brand-name GLP-1 across injectable and oral routes, microdosing, plus longevity, hair, and sexual-health lines — with transparent, all-inclusive pricing across all 50 states.
Marked down on: Compounded semaglutide and tirzepatide are not FDA-approved — not the same as Wegovy/Ozempic or Zepbound
RxSpan MD takes this head-to-head with the higher Desk Score, 86/100 (B) against 60/100 (C) for Alloy. Alloy still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Alloy
60/100
C
RxSpan MD
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Alloy | RxSpan MD |
|---|---|---|
| Semaglutide | $169/mo (compounded) | From $194/mo |
| Tirzepatide | $199/mo (compounded) | $329/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Readers who want menopause Society-certified care with the broadest GLP-1 formulary. | Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach. |
| Desk Score | 60/100C | 86/100B |
The verdict
Desk pick — RxSpan MDRxSpan MD takes this head-to-head with the higher Desk Score, 86/100 (B) against 60/100 (C) for Alloy. Alloy still holds its ground where its strengths line up with yours.
Choose Alloy if…
Readers who want menopause Society-certified care with the broadest GLP-1 formulary.
$169/mo (compounded) sema · $199/mo (compounded) tirz · Coverage not published
Choose RxSpan MD if…
Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach.
From $194/mo sema · $329/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Alloy · RxSpan MD.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Alloy vs CoreAge Rx
- RxSpan MD vs Vaylen
- Alloy vs Strut Health
- RxSpan MD vs Ondra Health
- Alloy vs Invigor Medical
- RxSpan MD vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.